Literature DB >> 7839087

Minimal cross-sectional areas, nasal peak flow and patients' satisfaction in septoplasty and inferior turbinectomy.

J Marais1, J A Murray, I Marshall, N Douglas, S Martin.   

Abstract

Changes in minimal cross-sectional areas, measured by acoustic rhinometry as well as nasal peak flow fractions and linear analogue patients' satisfaction scores, were measured in two groups of eight patients each, undergoing septoplasty alone and septoplasty combined with trimming of the inferior turbinates, respectively. Patients who had both procedures performed showed the greatest increase in both minimal cross-sectional areas and peak flow fractions, and both of these parameters were closely correlated with patients' satisfaction, whether the patient was satisfied or not. Pre-operative nasal obstruction was worse in the dual-procedure group, but post-operative satisfaction was significantly greater in these patients. Both acoustic rhinometry and nasal peak flow fractions can be recommended as accurate and easy to perform pre-operative measurements in patients undergoing surgery for nasal obstruction.

Entities:  

Mesh:

Year:  1994        PMID: 7839087

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  3 in total

1.  The relationship between nasal resistance to airflow and the airspace minimal cross-sectional area.

Authors:  Guilherme J M Garcia; Benjamin M Hariri; Ruchin G Patel; John S Rhee
Journal:  J Biomech       Date:  2016-04-01       Impact factor: 2.712

2.  Peak nasal inspiratory flow evaluation as an objective method of measuring nasal airflow.

Authors:  Rodrigo Ubiratan Franco Teixeira; Carlos Eduardo Monteiro Zappelini; Fábio Silva Alves; Everardo Andrade da Costa
Journal:  Braz J Otorhinolaryngol       Date:  2011 Jul-Aug

Review 3.  Objective monitoring of nasal patency and nasal physiology in rhinitis.

Authors:  Robert A Nathan; Ron Eccles; Peter H Howarth; Sverre K Steinsvåg; Alkis Togias
Journal:  J Allergy Clin Immunol       Date:  2005-03       Impact factor: 10.793

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.